Q4 & Full Year 2025 Earnings Presentation
📄 Download Full Presentation (PDF)Condensed Consolidated Statements
| Metric (in millions, except per share) | Q4 2024 | Q4 2025 | YoY Change | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | 21,720 | 24,840 | +14.4% | 84,310 | 93,850 |
| Gross Profit | 12,450 | 14,780 | +18.7% | 49,200 | 55,620 |
| Gross Margin | 57.3% | 59.5% | +220 bps | 58.4% | 59.3% |
| Operating Income | 6,100 | 7,055 | +15.7% | 23,850 | 26,640 |
| Operating Margin | 28.1% | 28.4% | +30 bps | 28.3% | 28.4% |
| Net Income | 5,020 | 5,680 | +13.1% | 19,100 | 21,340 |
| Diluted EPS | 4.31 | 4.82 | +11.8% | 16.20 | 18.15 |
| Free Cash Flow | 4,300 | 5,100 | +18.6% | 16,800 | 19,450 |
Segment Revenue & Growth
2026 Guidance & Strategic Outlook
Management reaffirms long-term strategic targets of 12-15% organic revenue growth and 30%+ operating margins. FY2026 investments will prioritize AI infrastructure scaling, next-gen fusion pilot plants, and cross-divisional automation platforms. Capital allocation remains balanced: 40% R&D, 30% CapEx, 20% M&A/strategic acquisitions, and 10% shareholder returns.
Forward-Looking Statements & Disclaimer
This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve risks, uncertainties, and assumptions that may cause actual results to differ materially. Factors include macroeconomic conditions, regulatory changes, supply chain disruptions, and competitive dynamics. Aevum Zenth Conglomerate undertakes no obligation to update these statements except as required by law. Historical results do not guarantee future performance. All financial data is unaudited and prepared in accordance with US GAAP.